Extreme hypofractionation for early prostate cancer: Biology meets technology
Authors:
- Berardino De BariBBBerardino De Bari
- Delia CiardoDCDelia Ciardo
- Rosario MazzolaRMRosario Mazzola
- Filippo AlongiFAFilippo Alongi
- on the behalf of the Italian Association of Radiation Oncology (AIRO)O(on the behalf of the Italian Association of Radiation Oncology (AIRO)
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 50, 48-60
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trialThe Lancet Oncology, 2016
- Global Cancer Incidence and Mortality Rates and Trends—An UpdateCancer Epidemiology, Biomarkers & Prevention, 2016
- Prostate cancerThe Lancet, 2016
- Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy for Clinically Localized Prostate Cancer: How Good Is the Evidence?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- A systematic review of randomised controlled trials of radiotherapy for localised prostate cancerEuropean Journal of Cancer, 2015
- EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013European Urology, 2014
- Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate CancerJournal of Clinical Oncology, 2013
- Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Carcinoma: Final Results of Phase III Randomized TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- A Prospective Phase III Randomized Trial of Hypofractionation Versus Conventional Fractionation in Patients With High-Risk Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate CancerJournal of Clinical Oncology, 2005